In this session, we'll discuss the pivotal role of infrastructure investments in accelerating the bioeconomy. Harnessing the full potential of synthetic biology requires access to expensive infrastructure for biomanufacturing and scale-up. We'll dive into how investors, CMOs, and startups are capitalizing on this opportunity space to accelerate bringing products to market.